Search
Alendronic acid
go.drugbank.com/drugs/DB00630ApprovedInvestigationalAlendronic acid is a second generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label] . It functions by preventing resorption of bone[FDA Label] .
Mixtures: ACIDO ALENDRONICO E COLECALCIFEROLO EG, ACIDO ALENDRONICO E COLECALCIFEROLO EGProducts: ALENDRONATO EG, ALENDRON HEXAL 70MG 1X WOEMirtazapine
go.drugbank.com/drugs/DB00370ApprovedInvestigationalMirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994. This drug was first manufactured by Organon Inc., and recei...
Products: MIRTAZAPINA EG, MIRTAZAPINA EG STADAFe(3+)-pyochelin receptor
go.drugbank.com/bio_entities/BE0004170TargetPseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)High-affinity outer membrane receptor required for the transport of Fe(3+)-pyochelin.
Polypeptides: Fe(3+)-pyochelin receptorSynonyms: Fe(III)-pyochelin receptorSymptom Complex, Triple
go.drugbank.com/conditions/DBCOND0088475Drugs: ColchicineSynonyms: Symptom Complex, TripleMethylprednisolone
go.drugbank.com/drugs/DB00959ApprovedInvestigationalVet approvedMethylprednisolone is a prednisolone derivative glucocorticoid with higher potency than prednisone. It was first described in the literature in the late 1950s. Methylprednisolone was granted FDA approval on 24 October 1957. In the outbre...
Mixtures: Physicians EZ Use M-pred, Physicians EZ Use M-predCategories: Sex Hormones and InsulinsSunitinib
go.drugbank.com/drugs/DB01268ApprovedInvestigationalSunitinib is a small-molecule multi-targeted receptor tyrosine kinase (RTK) inhibitor. On January 26, 2006, the agent was formally approved by the US FDA for the indications of treating renal cell carcinoma (RCC) and imatinib-resistant g...
Products: SUNITINIB EGVildagliptin
go.drugbank.com/drugs/DB04876ApprovedInvestigationalVildagliptin (LAF237) is an orally active antihyperglycemic agent that selectively inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme. It is used to manage type II diabetes mellitus, where GLP-1 secretion and insulinotropic effects are i...
Mixtures: VILDAGLIPTIN E METFORMINA SANDOZ, VILDAGLIPTIN E METFORMINA SANDOZProducts: VILDAGLIPTIN EGAmitriptyline
go.drugbank.com/drugs/DB00321ApprovedInvestigationalAmitriptyline is a tricyclic antidepressant that has been used to treat depression for decades. ELAVIL, a previously approved branded product of amitriptyline, was first approved by the FDA in 1961. Amitriptyline has been investigated in...
Products: AMITRIPTILINA EGFosfomycin
go.drugbank.com/drugs/DB00828ApprovedInvestigationalFosfomycin was discovered in 1969 by scientists at the Spanish Penicillin and Antibiotics Company and is produced by Streptomyces fradiae. It may also be produced synthetically and is commercially available as the disodium salt for intra...
Products: FOSFOMICINA EGCholecalciferol
go.drugbank.com/drugs/DB00169ApprovedInvestigationalNutraceuticalVitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results fro...
Mixtures: Active FE, Active FEProducts: COLECALCIFEROLO EG